Helomics Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 140

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $9.7M

Helomics General Information

Description

Provider of integrated clinical contract research and personalized medicine services intended to improve the standard of care for patients. The company's services offer advanced clinical laboratory diagnostic tests as well as scientific and non-scientific product enhancement services to provide customized and differentiated technologies to its clients in the pharmaceutical, diagnostic, biotechnology and research industries for their specific project needs, enabling patients to get better and more personalized treatments and diagnostic technologies for their diseases.

Contact Information

Website
www.helomics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 91 43rd Street
  • Suite 110
  • Pittsburgh, PA 15201
  • United States
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Acquirer
Predictive Oncology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 91 43rd Street
  • Suite 110
  • Pittsburgh, PA 15201
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Helomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 04-Apr-2019 $9.7M Completed Generating Revenue
13. Later Stage VC 01-Mar-2018 Completed Generating Revenue
12. Secondary Transaction - Private Completed Generating Revenue
11. Later Stage VC (Series A) 12-Nov-2014 Completed Generating Revenue
10. Later Stage VC 07-Aug-2013 Completed Generating Revenue
9. Mezzanine 31-Dec-2010 Completed Generating Revenue
8. Later Stage VC (Series D) 11-Jun-2010 Completed Generating Revenue
7. Later Stage VC (Series C) 10-Nov-2008 Completed Generating Revenue
6. Merger/Acquisition 04-Mar-2008 $151M Cancelled Generating Revenue
5. IPO 06-Dec-2007 $80.5M Cancelled Generating Revenue
To view Helomics’s complete valuation and funding history, request access »

Helomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Helomics’s complete cap table history, request access »

Helomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of integrated clinical contract research and personalized medicine services intended to improve the standard of
Biotechnology
Pittsburgh, PA
140 As of 2016

Germantown, NY
 

Carrollton, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Helomics Competitors (21)

One of Helomics’s 21 competitors is Taconic Biosciences, a Private Equity-Backed company based in Germantown, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taconic Biosciences Private Equity-Backed Germantown, NY
Gradalis Private Equity-Backed Carrollton, TX
Agilus Diagnostics Formerly PE-Backed Gurugram, India
Alturas Analytics Corporation Moscow, ID
Xencor Formerly VC-backed Pasadena, CA
You’re viewing 5 of 21 competitors. Get the full list »

Helomics Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Helomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180052168-A1 Ex vivo liquid biopsy Inactive 11-Mar-2016
US-20140052428-A1 Learning to predict effects of compounds on targets Inactive 14-Feb-2011
US-20200043575-A1 Electronic system with a data engine for processing retrieved data in displaying graphical data for a graphical user interface on an external input/output device Pending 14-Feb-2011
US-20120077687-A1 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy Inactive 18-Jun-2010
US-20140072999-A1 Methods of simulating chemotherapy for a patient Inactive 03-Nov-2008 G16H50/50
To view Helomics’s complete patent history, request access »

Helomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Helomics Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adams Capital Management Venture Capital Minority
Bain Capital Ventures Venture Capital Minority
Birchmere Ventures Venture Capital Minority
BoldCap Venture Capital Minority
Draper Fisher Jurvetson Management Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Helomics Investments (1)

Helomics’s most recent deal was a Joint Venture with Precision Oncology Insights platform. The deal was made on 09-Aug-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Precision Oncology Insights platform 09-Aug-2018 Joint Venture Drug Discovery
To view Helomics’s complete investments history, request access »

Ready to get started?

Request a free trial

Helomics FAQs

  • When was Helomics founded?

    Helomics was founded in 1995.

  • Where is Helomics headquartered?

    Helomics is headquartered in Pittsburgh, PA.

  • What is the size of Helomics?

    Helomics has 140 total employees.

  • What industry is Helomics in?

    Helomics’s primary industry is Biotechnology.

  • Is Helomics a private or public company?

    Helomics is a Private company.

  • What is the current valuation of Helomics?

    The current valuation of Helomics is .

  • What is Helomics’s current revenue?

    The current revenue for Helomics is .

  • How much funding has Helomics raised over time?

    Helomics has raised $252M.

  • Who are Helomics’s investors?

    Adams Capital Management, Bain Capital Ventures, Birchmere Ventures, BoldCap, and Draper Fisher Jurvetson Management are 5 of 17 investors who have invested in Helomics.

  • Who are Helomics’s competitors?

    Taconic Biosciences, Gradalis, Agilus Diagnostics, Alturas Analytics, and Xencor are some of the 21 competitors of Helomics.

  • When was Helomics acquired?

    Helomics was acquired on 04-Apr-2019.

  • Who acquired Helomics?

    Helomics was acquired by Predictive Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »